April 12, 2024
On a sunny Friday morning graduate students and postdocs gathered in a conference room in Stanley Hall to have an intimate and frank conversation with Annie Tsong, PhD. Tsong is…
January 22, 2024
Jaime Yassif is the Nuclear Threat Initiative’s vice president for Global Biological Policy and Programs and this month’s Professional in Residence at QB3-Berkeley. Yassif spoke to graduate student Sita Chandrasekaran…
November 30, 2023
Arne Bakker, PhD, is the director of Meetings and Community for Science at Chan Zuckerberg Initiative. The QB3-Berkeley Professionals in Residence program will be joined by Bakker on Friday, December…
April 18, 2023
Bilge Ozaydin is the Director of the Strain Discovery and Development group at Pivot Bio. The QB3-Berkeley Professionals in Residence program will be joined by Ozaydin on Friday, May 5th.…
January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In…